Abstract
Positivity rates for finding Chlamydia pneumoniae germs in atheroma depending on the methods used for detection vary from 0% to 100% (mean, 60%), with a few studies failing to detect the organisms by polymerase chain reaction (PCR). The many reviews on the subject of detection indicate increasing acceptance of the presence of Chlamydia organisms in human atherosclerotic lesions, but there are suggestions for a need to improve and standardize the diagnostic techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000;321:208–212.
Bloemenkamp DG, Mali WP, Visseren FL. Meta-analysis of sero-epidemiological studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results? Am Heart J 2003;145(3):409–417.
Wald NJ, Law MR, Morris JK, et al. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. BMJ 2000;321:204–207.
Puolakkainen M, Kuo C-C, Shor A, et al. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993;31(8):2212–2214.
Coutts WE, Davila M. Lymphogranuloma venereum as a possible cause of arteriosclerosis and other arterial conditions. J Trop Med Hyg 1945;48:46–51.
Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolaemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) Metabolic and molecular basis of inherited disease, 7th ed. New York: McGraw-Hill 1995:1981–2030.
Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolaemia: analysis of 16 patients. Am J Cardiol 1984;54:20–30.
Stehbens WE, Martin M. Case report. The vascular pathology of familial hypercholesterolaemia. Pathology 1991;23:1–54.
Shor A. Atherosclerotic lesions in a homozygous familial hypercholesterolaemic patient contains Chlamydia pneumoniae organisms. In: Lewis B, Halon DA, Flugelman MY, Hradec J (eds) Textbook on 4th international congress on coronary artery disease. Bologna, Italy: Monduzzi, 2000:227–230.
Shor A. Atherosclerosis lipid infiltration or Chlamydia pneumoniae infection. Circulation 2002;106(18)135e.
Melnick JL, Adam E, De Bakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA 1990;263:2204–2207.
Mattila KJ, Valtonen VV, Niemenin MS, et al. Role of infection as a risk factor for atherosclerosis, myocardial infection and stroke. Clin Infect Dis 1998;26:719–734.
Farsak B, Yildirir A, Akyon Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000;12(38):4408–4411.
Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. Periodontology 2000;71(10)1554–1560.
Moss NS, Benditt EP. The ultrastructure of spontaneous and experimentally induced arterial lesions. Lab Invest 1970;25(3):231–245.
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2007). Chlamydia Are Inherent Components of Atheroma. In: Chlamydia Atherosclerosis Lesion. Springer, London. https://doi.org/10.1007/978-1-84628-810-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-84628-810-4_9
Publisher Name: Springer, London
Print ISBN: 978-1-84628-809-8
Online ISBN: 978-1-84628-810-4
eBook Packages: MedicineMedicine (R0)